Molecular Basis of Antidiabetogenic Hormone Action
抗糖尿病激素作用的分子基础
基本信息
- 批准号:7340179
- 负责人:
- 金额:$ 1.62万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-01-15 至 2008-02-29
- 项目状态:已结题
- 来源:
- 关键词:Adenylate CyclaseAffinityAmidesAnabolismBeta CellBindingBiological AssayBlood GlucoseCell membraneCell physiologyCellsClassComplexConditionCouplesCyclic AMPCyclic AMP-Dependent Protein KinasesDiabetes MellitusDominant-Negative MutationEGF geneElectric CapacitanceEndoplasmic ReticulumEpitopesExocytosisFamilyFundingGLP-I receptorGenerationsGoalsGrowth FactorGrowth Factor ReceptorsGuanine Nucleotide Exchange FactorsGuanosine Triphosphate PhosphohydrolasesHormonesHumanIn VitroInsulinInsulin-Like Growth Factor IInvestigationIslets of LangerhansKnockout MiceLaboratoriesLeadLinkMeasurementMeasuresMediatingMembraneMolecularNaturePancreasPatch-Clamp TechniquesPlayProcessProductionPropertyProtein IsoformsProtein OverexpressionProtein Tyrosine KinaseProteinsRALGDS geneRecruitment ActivityRegulationResearch PersonnelRodentRoleRyanodine Receptor Calcium Release ChannelSecond Messenger SystemsSignal PathwaySignal TransductionSignal Transduction PathwaySignaling MoleculeSourceStimulusStructure of beta Cell of isletTestingTherapeuticTransfectionadenosine cyclic-3&apos,5&apos-monophosphate binding proteinsanalogbasecell growthdiabeticglucagon-like peptide 1inositol-1,4,5-triphosphate receptorinsulin secretioninterestisletkidney cellmimeticsnovelpeptide analogphospholipase C epsilonprogramsral Guanine Nucleotide Exchange Factorsecond messengersensorsulfonylurea receptorsynthetic peptidevoltage
项目摘要
An emerging theme in experimental therapeutics concerns the use of glucagon-like peptide-1-(7-36)-
amide (GLP-1) and its synthetic peptide analogs (the "incretin mimetics") to lower levels of blood glucose
in Type 2 diabetic subjects. This action of GLP-1 results, at least in part, from its ability to stimulate the
secretion of insulin from pancreatic beta cells located in the islets of Langerhans. Given the established
importance of GLP-1 for the treatment of diabetes, our laboratory is interested in defining the signal
transduction properties of the beta cell GLP-1 receptor (GLP-1-R). To this end, we have focused on a
newly-discovered signaling mechanism that uses the second messenger cAMP to activate cAMP-
regulated guanine nucleotide exchange factors designated as Epad and Epac2 (the Exchange Proteins
directly Activated by Cyclic AMP). Our studies lead us to Hypothesize that GLP-1, a cAMP-elevating
hormone, stimulates Ca2+-dependent insulin secretion, and that this insulinotropic action is mediated not
simply by protein kinase A (PKA), but also by Epac. To test our Hypothesis concerning the putative role
of Epac in GLP-1-R-mediated signal transduction, the Specific Aims of this project are to: 1) determine if
GLP-1 uses Epad and/or Epac2 to mobilize intracellular Ca2+ via a process of Ca2+-induced Ca2+
release (CICR) that originates at the endoplasmic reticulum (ER) and which may involve IP3 receptors or
ryanodine receptors, 2) assess what role Rap family GTPases play in the process of ER Ca2"1"
mobilization, with special emphasis on the potential role of Rap1 as an intermediary linking activation of
Epac to the stimulation of phospholipase C-epsilon, and 3) determine the nature of a novel signaling
mechanism by which beta cell growth factors and receptor tyrosine kinases utilize the Ras GTPases to
recruit Epac2 to the plasma membrane where an interaction of Epac2 with its putative effector molecule
the sulfonylurea receptor-1 (SUR1) occurs. The Relevance of this line of investigation is fully apparent.
We wish to establish the molecular basis for "antidiabetogenic" properties of a new class of blood
glucose-lowering agents that activate the GLP-1-R and which stimulate pancreatic insulin secretion.
实验治疗中的一个新兴主题涉及使用胰高血糖素样肽-1-(7-36)-
酰胺(GLP-1)及其合成肽类似物(“肠促胰岛素模拟物”)来降低血糖水平
在2型糖尿病患者中。GLP-1的这一作用至少部分是由于其能够刺激细胞增殖,
胰岛β细胞分泌胰岛素。鉴于既定的
GLP-1对糖尿病治疗的重要性,我们的实验室有兴趣定义信号
β细胞GLP-1受体(GLP-1-R)的转导特性。为此,我们集中精力,
新发现的信号机制,使用第二信使cAMP激活cAMP-
被命名为Epad和Epac 2的受调节的鸟嘌呤核苷酸交换因子(交换蛋白
直接由环AMP激活)。我们的研究使我们假设GLP-1,一种cAMP升高因子,
激素,刺激Ca 2+依赖性胰岛素分泌,这种促胰岛素作用不受
蛋白激酶A(PKA),以及Epac。为了验证我们的假设,
Epac在GLP-1-R介导的信号转导中的作用,本项目的具体目的是:1)确定
GLP-1使用Epad和/或Epac 2通过Ca 2+诱导的Ca 2+转运过程来动员细胞内Ca 2+。
在某些实施方案中,所述细胞释放是源自内质网(ER)并且可能涉及IP 3受体的细胞释放(CICR),或
Ryanodine受体,2)评估Rap家族GTPases在ER Ca 2+过程中发挥的作用。
动员,特别强调Rap 1作为连接激活的中间体的潜在作用,
Epac对磷脂酶C-β的刺激,以及3)确定一种新的信号传导的性质
β细胞生长因子和受体酪氨酸激酶利用Ras GTP酶
将Epac 2募集到质膜,在质膜Epac 2与其推定的效应分子的相互作用
磺酰脲受体-1(SUR 1)。这条调查路线的相关性是显而易见的。
我们希望建立一种新的血液类型的“抗糖尿病”特性的分子基础。
激活GLP-1-R并刺激胰腺胰岛素分泌的降糖药。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
GEORGE G HOLZ其他文献
GEORGE G HOLZ的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('GEORGE G HOLZ', 18)}}的其他基金
Alpha7 Nicotinic Acetylcholine Receptor Regulation of Glucagon-Like Peptide- 1 Incretin Hormone Action.
Alpha7 烟碱乙酰胆碱受体对胰高血糖素样肽 - 1 肠促胰岛素激素作用的调节。
- 批准号:
10218302 - 财政年份:2020
- 资助金额:
$ 1.62万 - 项目类别:
Alpha7 Nicotinic Acetylcholine Receptor Regulation of Glucagon-Like Peptide-1 Incretin Hormone Action.
Alpha7 烟碱乙酰胆碱受体对胰高血糖素样肽-1 肠促胰岛素激素作用的调节。
- 批准号:
10350680 - 财政年份:2020
- 资助金额:
$ 1.62万 - 项目类别:
Alpha7 Nicotinic Acetylcholine Receptor Regulation of Glucagon-Like Peptide-1 Incretin Hormone Action.
Alpha7 烟碱乙酰胆碱受体对胰高血糖素样肽-1 肠促胰岛素激素作用的调节。
- 批准号:
10570210 - 财政年份:2020
- 资助金额:
$ 1.62万 - 项目类别:
Molecular Basis of Antidiabetogenic Hormone Action
抗糖尿病激素作用的分子基础
- 批准号:
8825035 - 财政年份:2014
- 资助金额:
$ 1.62万 - 项目类别:
Molecular Basis of Antidiabetogenic Hormone Action
抗糖尿病激素作用的分子基础
- 批准号:
8929209 - 财政年份:2014
- 资助金额:
$ 1.62万 - 项目类别:
Molecular Basis of Antidiabetogenic Hormone Action
抗糖尿病激素作用的分子基础
- 批准号:
9334841 - 财政年份:2014
- 资助金额:
$ 1.62万 - 项目类别:
Molecular Basis of Antidiabetogenic Hormone Action
抗糖尿病激素作用的分子基础
- 批准号:
8013710 - 财政年份:2010
- 资助金额:
$ 1.62万 - 项目类别:
Molecular Basis of Antidiabetogenic Hormone Action
抗糖尿病激素作用的分子基础
- 批准号:
7535564 - 财政年份:2007
- 资助金额:
$ 1.62万 - 项目类别:
THE MECHANISM OF ACTION OF A NEWLY DEVELOPED BLOOD GLUCOSE-LOWERING HORMONE
新开发的降血糖激素的作用机制
- 批准号:
7721088 - 财政年份:2007
- 资助金额:
$ 1.62万 - 项目类别:
Molecular Basis of Antidiabetogenic Hormone Action
抗糖尿病激素作用的分子基础
- 批准号:
7623292 - 财政年份:2007
- 资助金额:
$ 1.62万 - 项目类别:
相似海外基金
Construction of affinity sensors using high-speed oscillation of nanomaterials
利用纳米材料高速振荡构建亲和传感器
- 批准号:
23H01982 - 财政年份:2023
- 资助金额:
$ 1.62万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Affinity evaluation for development of polymer nanocomposites with high thermal conductivity and interfacial molecular design
高导热率聚合物纳米复合材料开发和界面分子设计的亲和力评估
- 批准号:
23KJ0116 - 财政年份:2023
- 资助金额:
$ 1.62万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Development of High-Affinity and Selective Ligands as a Pharmacological Tool for the Dopamine D4 Receptor (D4R) Subtype Variants
开发高亲和力和选择性配体作为多巴胺 D4 受体 (D4R) 亚型变体的药理学工具
- 批准号:
10682794 - 财政年份:2023
- 资助金额:
$ 1.62万 - 项目类别:
Platform for the High Throughput Generation and Validation of Affinity Reagents
用于高通量生成和亲和试剂验证的平台
- 批准号:
10598276 - 财政年份:2023
- 资助金额:
$ 1.62万 - 项目类别:
Collaborative Research: DESIGN: Co-creation of affinity groups to facilitate diverse & inclusive ornithological societies
合作研究:设计:共同创建亲和团体以促进多元化
- 批准号:
2233343 - 财政年份:2023
- 资助金额:
$ 1.62万 - 项目类别:
Standard Grant
Collaborative Research: DESIGN: Co-creation of affinity groups to facilitate diverse & inclusive ornithological societies
合作研究:设计:共同创建亲和团体以促进多元化
- 批准号:
2233342 - 财政年份:2023
- 资助金额:
$ 1.62万 - 项目类别:
Standard Grant
Molecular mechanisms underlying high-affinity and isotype switched antibody responses
高亲和力和同种型转换抗体反应的分子机制
- 批准号:
479363 - 财政年份:2023
- 资助金额:
$ 1.62万 - 项目类别:
Operating Grants
Deconstructed T cell antigen recognition: Separation of affinity from bond lifetime
解构 T 细胞抗原识别:亲和力与键寿命的分离
- 批准号:
10681989 - 财政年份:2023
- 资助金额:
$ 1.62万 - 项目类别:
CAREER: Engineered Affinity-Based Biomaterials for Harnessing the Stem Cell Secretome
职业:基于亲和力的工程生物材料用于利用干细胞分泌组
- 批准号:
2237240 - 财政年份:2023
- 资助金额:
$ 1.62万 - 项目类别:
Continuing Grant
ADVANCE Partnership: Leveraging Intersectionality and Engineering Affinity groups in Industrial Engineering and Operations Research (LINEAGE)
ADVANCE 合作伙伴关系:利用工业工程和运筹学 (LINEAGE) 领域的交叉性和工程亲和力团体
- 批准号:
2305592 - 财政年份:2023
- 资助金额:
$ 1.62万 - 项目类别:
Continuing Grant